USD
$0.00
(0.00%
)At Close (As of Sep 15, 2025)
$1.37B
Market Cap
-
P/E Ratio
-2.48
EPS
$28.47
52 Week High
$16.60
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $132M |
Total Revenue | $208M |
Cost Of Revenue | $75M |
Costof Goods And Services Sold | $75M |
Operating Income | -$209M |
Selling General And Administrative | $100M |
Research And Development | $202M |
Operating Expenses | $341M |
Investment Income Net | - |
Net Interest Income | - |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | - |
Income Before Tax | -$186M |
Income Tax Expense | $1.4M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$187M |
Comprehensive Income Net Of Tax | - |
Ebit | -$209M |
Ebitda | -$209M |
Net Income | -$187M |
Field | Value (USD) |
---|---|
Total Assets | $823M |
Total Current Assets | $635M |
Cash And Cash Equivalents At Carrying Value | $147M |
Cash And Short Term Investments | $147M |
Inventory | - |
Current Net Receivables | $255M |
Total Non Current Assets | $188M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | $4.8M |
Investments | - |
Long Term Investments | $43M |
Short Term Investments | $205M |
Other Current Assets | $28M |
Other Non Current Assets | - |
Total Liabilities | $402M |
Total Current Liabilities | $192M |
Current Accounts Payable | $11M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $17M |
Total Non Current Liabilities | $210M |
Capital Lease Obligations | $118M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $118M |
Other Current Liabilities | $52M |
Other Non Current Liabilities | $146K |
Total Shareholder Equity | $421M |
Treasury Stock | - |
Retained Earnings | -$526M |
Common Stock | $637K |
Common Stock Shares Outstanding | $73M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$157M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $6.2M |
Capital Expenditures | $7.3M |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | $149M |
Cashflow From Financing | $10M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$187M |
Field | Value (USD) |
---|---|
Gross Profit | $132M |
Total Revenue | $208M |
Cost Of Revenue | $75M |
Costof Goods And Services Sold | $75M |
Operating Income | -$209M |
Selling General And Administrative | $100M |
Research And Development | $202M |
Operating Expenses | $341M |
Investment Income Net | - |
Net Interest Income | - |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | - |
Income Before Tax | -$186M |
Income Tax Expense | $1.4M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$187M |
Comprehensive Income Net Of Tax | - |
Ebit | -$209M |
Ebitda | -$209M |
Net Income | -$187M |
Sector: HEALTHCARE
Industry: HEALTH INFORMATION SERVICES
Schrdinger, Inc. provides a physics-based software platform that enables the discovery of novel molecules for drug development and material applications. The company is headquartered in New York, New York.